4//SEC Filing
Sablich Kim 4
Accession 0001209191-21-028175
CIK 0001305253other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 5:35 PM ET
Size
5.4 KB
Accession
0001209191-21-028175
Insider Transaction Report
Form 4
Sablich Kim
Director
Transactions
- Award
Stock Option (right to buy)
2021-04-23+25,000→ 25,000 totalExercise: $8.43Exp: 2031-04-22→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from April 23, 2019 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001758790
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 5:35 PM ET
- Size
- 5.4 KB